These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8794165)

  • 21. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
    Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
    Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.
    Nagababu E; Ramasamy S; Rifkind JM; Jia Y; Alayash AI
    Biochemistry; 2002 Jun; 41(23):7407-15. PubMed ID: 12044174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobin-based blood substitutes and the hazards of blood radicals.
    Alayash AI
    Free Radic Res; 2000 Oct; 33(4):341-8. PubMed ID: 11022843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood substitutes.
    Palmer AF; Intaglietta M
    Annu Rev Biomed Eng; 2014 Jul; 16():77-101. PubMed ID: 24819476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC).
    Cooper CE; Silaghi-Dumitrescu R; Rukengwa M; Alayash AI; Buehler PW
    Biochim Biophys Acta; 2008 Oct; 1784(10):1415-20. PubMed ID: 18457681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red cell substitutes from hemoglobin--do we start all over again?
    Kluger R
    Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on alternative oxygen carriers.
    Hess JR
    Vox Sang; 2004 Jul; 87 Suppl 2():132-5. PubMed ID: 15209897
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
    Napolitano LM
    Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood substitutes: state of the art and technical setbacks and why we are still disappointed].
    Vigneron C; Smani Y; Faivre B
    Bull Acad Natl Med; 2007; 191(4-5):837-47; discussion 847. PubMed ID: 18225438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood substitutes. What they are and how they might be used.
    Dong Q; Stowell CP
    Am J Clin Pathol; 2002 Dec; 118 Suppl():S71-80. PubMed ID: 14569814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in the peripheral blood, liver and spleen during the long-term experimental administration of modified hemoglobin].
    Selivanov EA; Shabalin VN; Bystrova IM; Molokovskaia IE; Rugal' VI
    Biull Eksp Biol Med; 1989 Apr; 107(4):488-90. PubMed ID: 2720169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified haemoglobins as oxygen-transporting blood substitutes.
    Mallick A; Bodenham AR
    Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
    Buehler PW; D'Agnillo F; Schaer DJ
    Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
    Chang TM
    Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant haemoglobin in the development of red-blood-cell substitutes.
    Ogden JE
    Trends Biotechnol; 1992 Mar; 10(3):91-6. PubMed ID: 1367945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of blood substitute research: towards a new paradigm.
    Winslow RM
    J Intern Med; 2003 May; 253(5):508-17. PubMed ID: 12702028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All hemoglobin-based oxygen carriers are not created equally.
    Buehler PW; Alayash AI
    Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating new red cell substitutes: a critical analysis of toxicity models.
    Greenburg AG; Kim HW
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):575-9. PubMed ID: 1391480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.
    Patel RP
    Free Radic Biol Med; 2000 May; 28(10):1518-25. PubMed ID: 10927176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.